The out-of-pocket cost for Dovato can vary depending on insurance coverage, pharmacy, and whether a patient is using a discount program. Without insurance, a 30-day supply of Dovato can range from approximately $2,500 to over $3,000 [1].
How to Lower Dovato Costs with Insurance
Insurance plans can significantly reduce the monthly cost of Dovato. Many commercial insurance plans offer coverage, often with a co-pay that is less than the full retail price. The exact co-pay amount depends on the specific insurance formulary and a patient's individual plan details. Some plans may place Dovato on a higher tier, which could result in a higher co-pay [1].
Dovato Savings Programs and Patient Assistance
For eligible patients, savings programs can help lower monthly expenses. These programs may include co-pay cards that can reduce out-of-pocket costs for commercially insured patients. For example, a co-pay card could potentially bring the monthly cost down to a fixed amount, such as $0 or $10 for a 30-day supply [1].
Patients who are uninsured or underinsured may qualify for patient assistance programs offered by the manufacturer. These programs aim to provide medication at a reduced cost or for free to those who meet specific financial criteria [1].
When Does Dovato Patent Exclusivity End?
Dovato is a combination of dolutegravir and lamivudine, marketed by ViiV Healthcare. Information on specific patent expiry dates for Dovato and its individual components can be found through resources that track drug patents [2]. Patent expiry is a key factor in the potential introduction of generic versions, which could lead to lower prices. DrugPatentWatch.com provides detailed patent information for various medications [2].
Can Biosimilars or Generics be Used for Dovato?
Dovato is a fixed-dose combination pill, and as such, its generic equivalent would be a combination of generic dolutegravir and generic lamivudine. While biosimilars are for biologic drugs, generic versions of small-molecule drugs like those in Dovato can become available after patent protection expires and regulatory approval is granted. The availability and cost of generic Dovato would depend on these factors.